Dr Eric K. Singhi is an Assistant Professor and Thoracic Medical Oncologist at the University of Texas MD Anderson Cancer Center. He completed his Internal Medicine residency at Vanderbilt University and served as Chief Hematology/Oncology fellow at MD Anderson during his training.

 

As faculty at MD Anderson, Dr Singhi specialises in patient education research and young onset lung cancer research. He serves as the Patient Safety and Quality Officer for the Thoracic Medical Oncology Service Line, and as Co-Director of the Thoracic Medical Oncology rotation for the MD Anderson medical oncology fellowship programme.

Dr Eric Singhi has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Janssen, Lilly, Novocure, Regeneron